Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference

BOULDER, Colo., Sept. 2, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference in Boston.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   


Wells Fargo Securities Healthcare Conference


Ron Squarer, Chief Executive Officer


Thursday, September 10, 2015


10:20 a.m. Eastern Time



Array BioPharma.

About Array BioPharma 
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to


Tricia Haugeto

Array BioPharma Inc.


Logo -


To view the original version on PR Newswire, visit:

SOURCE Array BioPharma Inc.